Stay updated on PM01183 Escalating Doses with Doxorubicin Clinical Trial
Sign up to get notified when there's something new on the PM01183 Escalating Doses with Doxorubicin Clinical Trial page.

Latest updates to the PM01183 Escalating Doses with Doxorubicin Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now shows the latest revision as v3.5.3, replacing the previous v3.5.2 in the study record history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded Revision: v3.5.2 to the study record version history. Removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded revision v3.4.3 to the Record History and removed revision v3.4.2 from the list.SummaryDifference0.1%

- Check88 days agoChange DetectedA new record revision, Revision: v3.4.2, was added to the study history. The funding-status notice banner explaining government operating status was removed.SummaryDifference0.7%

- Check95 days agoChange DetectedAdded a government funding notice banner and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.7%

Stay in the know with updates to PM01183 Escalating Doses with Doxorubicin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PM01183 Escalating Doses with Doxorubicin Clinical Trial page.